ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NPTH Enpath Medical (MM)

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Enpath Medical (MM) NASDAQ:NPTH NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Enpath Medical Announces Fourth Quarter 2006 Earnings Release and Conference Call Date

14/02/2007 4:02pm

PR Newswire (US)


Enpath (NASDAQ:NPTH)
Historical Stock Chart


From Dec 2019 to Dec 2024

Click Here for more Enpath Charts.
MINNEAPOLIS, Feb. 14 /PRNewswire-FirstCall/ -- Enpath Medical, Inc. (NASDAQ:NPTH) announced today that it will release its fourth quarter 2006 financial results at the close of market on Thursday, February 22, 2007. The management team of Enpath Medical will host a conference call to discuss the results beginning at 3:30 P.M. Central Time, also on Thursday, February 22, 2007. To participate, please call 800-240-5318 for domestic callers and 303-262-2175 for international callers. A recording of the conference call will be available approximately one hour after the conclusion of the call and will be accessible for seven days. To access the replay, please dial 800-405-2236 for domestic callers and 303-590-3000 for international callers; please reference the pass code 11083852#. The conference call will also be webcast live on the company's web site, http://www.enpathmed.com/ , and may be accessed by clicking on the 4th Quarter 2006 Earnings Call icon. An audio replay will be archived on the Enpath website for one year. About Enpath Medical Enpath Medical, Inc., headquartered in Plymouth, Minnesota, is a leader in the design, development, manufacture and marketing of percutaneous delivery systems and stimulation leads technologies. Its proprietary products include venous vessel introducers, articulating and fixed curve delivery catheters, epicardial and endocardial stimulation leads, and other products for use in pacemaker, defibrillator, catheter and infusion port procedures as well as neuromodulation markets. Its products, which are primarily finished goods, are sold worldwide through partnering relationships with other medical device companies. DATASOURCE: Enpath Medical, Inc. CONTACT: Investors, Doug Sherk or Jennifer Beugelmans, +1-646-201-5447, or Media, Steve DiMattia, +1-646-201-5445, all of EVC Group for Enpath Medical, Inc. Web site: http://www.enpathmed.com/

Copyright

1 Year Enpath Chart

1 Year Enpath Chart

1 Month Enpath Chart

1 Month Enpath Chart

Your Recent History

Delayed Upgrade Clock